MetLife Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History

MetLife Investment Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-25,529	Closed	-$80.4K	–	2356
2020 Q3	$80.4K	Sell	25,529 -27,247	-52%	-$87K	﹤0.01%	2248
2020 Q2	$154K	Hold	52,776	–	–	﹤0.01%	2050
2020 Q1	$149K	Sell	52,776 -23,225	-31%	-$74.9K	﹤0.01%	1858
2019 Q4	$247K	Hold	76,001	–	–	﹤0.01%	1862
2019 Q3	$164K	Hold	76,001	–	–	﹤0.01%	2054
2019 Q2	$239K	Hold	76,001	–	–	﹤0.01%	1924
2019 Q1	$283K	Hold	76,001	–	–	﹤0.01%	1783
2018 Q4	$220K	Hold	76,001	–	–	﹤0.01%	1856
2018 Q3	$200K	Hold	76,001	–	–	﹤0.01%	2082
2018 Q2	$178K	Buy	76,001 +34,078	+81%	+$95.1K	﹤0.01%	1975
2018 Q1	$123K	Sell	41,923 -35,608	-46%	-$97.2K	﹤0.01%	2121
2017 Q4	$212K	Buy	+77,531	New	+$238K	﹤0.01%	1903

Other funds holding PDLI

SPC

Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.46% 1-Year Est. Return

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

MetLife Investment Management's PDLI Position: Q4 2020 in Review

MetLife Investment Management sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 25,529 shares — an estimated $80.4K sold.

MetLife Investment Management first reported a position in PDLI in Q4 2017 and held it in 12 quarters. The position peaked at $283K in Q1 2019. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

MetLife Investment Management reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
MetLife Investment Management sold 25,529 PDL BioPharma, Inc. shares in Q4 2020, an estimated $80.4K.
MetLife Investment Management first reported a position in PDL BioPharma, Inc. in Q4 2017 and held it in 12 quarters.
MetLife Investment Management's PDL BioPharma, Inc. position peaked at $283K in Q1 2019.
33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on MetLife Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.